The views, information, or opinions expressed in the Industry News RSS feed belong solely to the author and do not necessarily represent those of IDEX Health & Science and its employees.
Article obtained from BioPhotonics RSS Feed.
AngioDynamics has acquired Eximo Medical and its proprietary 355-nm wavelength laser technology platform. The transaction came in a $46 million upfront consideration with up to $20 million of contingent consideration related to certain technical and revenue milestones. The transaction is being funded exclusively through the use of cash on hand.
The transaction expands AngioDynamics’ existing Vascular Interventions and Therapies (VIT) product portfolio by adding Eximo’s proprietary laser technology, which has received 510(k) clearance for use in the treatment of peripheral artery disease.
Eximo’s laser technology delivers short, high-powered pulses in 355-nm wavelength without compromising the integrity of its…READ MORE